GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVE Science & Technology Co Ltd (SHSE:688067) » Definitions » Debt-to-EBITDA

AVE Science & Technology Co (SHSE:688067) Debt-to-EBITDA : 0.00 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is AVE Science & Technology Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

AVE Science & Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥0.0 Mil. AVE Science & Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥0.0 Mil. AVE Science & Technology Co's annualized EBITDA for the quarter that ended in Sep. 2024 was ¥52.2 Mil. AVE Science & Technology Co's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for AVE Science & Technology Co's Debt-to-EBITDA or its related term are showing as below:

SHSE:688067's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.54
* Ranked among companies with meaningful Debt-to-EBITDA only.

AVE Science & Technology Co Debt-to-EBITDA Historical Data

The historical data trend for AVE Science & Technology Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVE Science & Technology Co Debt-to-EBITDA Chart

AVE Science & Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AVE Science & Technology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AVE Science & Technology Co's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, AVE Science & Technology Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVE Science & Technology Co's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVE Science & Technology Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AVE Science & Technology Co's Debt-to-EBITDA falls into.



AVE Science & Technology Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

AVE Science & Technology Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 27.825
=0.00

AVE Science & Technology Co's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 52.248
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


AVE Science & Technology Co  (SHSE:688067) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


AVE Science & Technology Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AVE Science & Technology Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AVE Science & Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No.27 Wenxuan Road, Building B6, Lugu Yuyuan, High-tech Development Zone, Hunan Province, Changsha, CHN, 410205
AVE Science & Technology Co Ltd is engaged in the research and development, production, sales and service of medical clinical laboratory analysis instruments and supporting in vitro diagnostic reagents and medical consumables.
Executives
Li Rong Core technical personnel

AVE Science & Technology Co Headlines

No Headlines